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ABSTRACT 
This review concerns a number of substances which have been receiving much attention, 
particularly in the media, for their potential to protect against age-related cognitive decline, and a 
focus is placed upon recent findings. Omega-3 fatty acids appear to play important roles in 
preserving neuronal structure and function and minimizing cognitive decline, while antioxidant 
vitamins C and E appear to be particularly beneficial for combating age-related oxidative stress 
when administered in combination. Fruit and vegetable polyphenols also offer great potential, 
although most research thus far has involved rodents. Finally, there is mixed evidence regarding the 
cognitive enhancing properties of Ginkgo biloba, and the B vitamins folate and cobalamin, with all 
of these requiring further investigation. 
Keywords: Cognition; Aging; Ageing; n-3 fatty acids; flavonoids; blueberries; vitamin B-9; vitamin 
B-12. 
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Advancing age is accompanied by the decline of cognitive abilities such as perceptual speed, 
reasoning, episodic memory, and working memory. Conversely, well-practised tasks or those 
involving a knowledge base (e.g., vocabulary, semantic memory) show less decline, while some 
abilities appear to remain stable throughout life (e.g., autobiographical memory, emotional 
processing, and automatic memory processes; for a review, see Hedden & Gabrieli, 2004). 
Crucially, those cognitive abilities which do suffer age-related decline impact significantly upon the 
everyday lives of older adults. For example, older adults exhibit reduced performance on tests 
indexing the instrumental activities of daily living (ADL) involving tasks such as taking 
medications, meal preparation, and telephone usage (Burton, Strauss, Hultsch, & Hunter, 2006). 
Furthermore, older adults who have been diagnosed with mild cognitive impairment (MCI), a 
borderline state between age-related cognitive decline and mild dementia, have been found to 
exhibit more severe deficits on most elements of complex ADL, including finding items in the 
home, keeping appointments, remembering information from newspapers or the television, and 
talking about recent events (Perneczky et al., 2006). It is therefore clear that age-related cognitive 
impairment may impact significantly on the everyday lives of older adults. 
In recent years there has been increasing interest, particularly within the media, in the variety 
of interventions which may help to improve cognitive performance in older age, such as nutritional 
supplementation, cognitive training, and physical activity. Since a number of nutritional 
supplements have shown the potential to slow or even reverse age-related cognitive decline, and 
have received much media attention in this light, it is timely that the present article reviews the 
facilitative effects of these substances in older age. The reviewed substances include both macro-
and micronutrients and one herbal extract which has shown promise. Specifically, omega-3 fatty 
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acids, antioxidant vitamins C and E, the B vitamins folate and cobalamin, fruit and vegetable 
polyphenols, and ginkgo biloba are discussed. 
Omega-3 Fatty Acids 
Omega-3 fatty acids are a type of polyunsaturated fatty acid, derived from various fish and plants 
(e.g., salmon, mackerel, tuna, soybeans, pumpkin seeds, and walnuts), which have received research 
attention for emphasizing the potential benefits of use with older adults. It is believed that changes 
in the typical ‘European diet’ have resulted in a decline in the natural intake of omega-3 fatty acids 
(Sanders, 2000), which may have implications in terms of age-related health risks. As well as 
cognitive dysfunction, various health risks of deficient dietary omega-3 have been widely reported 
(e.g., cardiovascular disease). At the cellular level, deficiencies in omega-3 can affect the chemical 
composition of neuronal cell membranes and influence neurotransmission processes (Mazza, 
Pomponi, Janiri, Bria, & Mazza, 2007). Importantly, the cognitive benefits of adequate dietary 
omega-3 have been linked to two compounds; namely eicosapentaenoic acid (EPA) and 
docosahexaenoic acid (DHA), both largely derived from fish oil and particularly important for 
maintaining healthy cell function (Yuen, Sander, Fluegel, & Patsalos, 2005). 
Correlational studies have investigated the relationship between fish and seafood consumption 
and dementia, and it has been found that the intake of fish or seafood at least once a week is 
associated with a decreased risk of developing dementia and the accompanying cognitive decline 
(Barberger-Gateau et al., 2002). Indeed, the consequences of consuming one fish meal per week 
and two or more fish meals per week is reported to be a 10% and 13% reduction in the rate of 
cognitive decline, respectively (Morris, Evans, Tangney, Bienias, & Wilson, 2005). However, two 
limitations of these studies need to be considered. First, work of this nature would benefit from 
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greater specificity of the fish or seafood consumed, since omega-3 fatty acid concentration varies 
between fish and seafood products (for estimates, see Mozaffarian & Rimm, 2006). Second, it is not 
possible to determine the precise nature of cognitive functions moderated by the intake of omega-3, 
as global measures of cognition have typically been utilized. A recent study by Dangour et al. 
(2009) revealed positive associations between fish consumption (via assessment of frequency and 
type of fish consumed), and a range of cognitive outcomes including memory and executive 
function, in 867 cognitively healthy older adults aged 70-79 years. Notably, however, the 
relationships were attenuated after adjustments for factors such as education and psychological 
health. 
Additional insights into the protective effect of polyunsaturated fatty acids come from the 
findings that neuronal cell membrane compositions exhibit a decrease in Alzheimer’s disease (AD; 
e.g., Guan, Soderberg, Sindelar, & Edlund, 1994) and that, in AD patients, a specific deficit may 
exist in DHA levels in the hippocampus, a key structure involved in learning and memory (Lukiw et 
al., 2005). Overall, it has been highlighted that DHA plays an important role in cognitive 
functioning since it is critical to cell survival (Mazza et al., 2007; see also Lukiw & Bazan, 2008). 
Studies have investigated DHA and cognitive performance in MCI and, in a study by Kotani et al. 
(2006), cognitive dysfunction (memory and attention) brought about by MCI or organic brain 
damage was found to be improved by 240 mg/day of a combination of two fatty acids, namely 
arachidonic acid (AA; omega-6) and DHA (omega-3); however, no such improvement was found 
for AD patients. Kroger et al. (2009), who also adjusted for the influence of apolipoprotein E 
(APOE) allele type, found no relationship between erythroycte membrane omega-3 fatty acids and 
risk of dementia. On the other hand, though, Whalley et al. (2008) found a positive association 
between erythrocyte membrane omega-3 fatty acids and cognitive performance in non-demented 
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older adults. This association remained after adjustment for factors including intelligence at age 11 
years, but existed only in the absence of the APOE ε4 allele, suggesting a gene x environment 
interaction in this population. 
The inclusion of AA in the study by Kotani et al. (2006) brings into question the potential role 
for omega-6 fatty acids, derived mainly from vegetable oil (Mazza et al., 2007). However, in 
contrast with the decrease in omega-3 intake, omega-6 has actually shown an increase in western 
diets (e.g., see Ruxton, Reed, Simpson, & Millington, 2007; Sanders, 2000). Also, as Youdim, 
Martin, and Joseph (2000) have highlighted, although omega-6 fatty acids are also present, the brain 
is particularly rich in omega-3 fatty acids such as DHA (see also Dangour, Sibson, & Fletcher, 
2004). Because it is important to achieve the correct balance of these substances for healthy brain 
function, and due to the evidence of altered intake, the current focus should be placed upon 
supplementation with omega-3 fatty acids. 
Indeed, work involving rodents suggests that cognitive behavior is related to DHA status 
(Moriguchi, Greiner, & Salem, 2000) and that treatment with DHA can reduce the decline of such 
abilities in an AD model (Hashimoto et al., 2002). This study, which showed the beneficial effect of 
DHA on episodic memory (avoidance learning ability) in AD model rats, also found an associated 
increase in DHA cortico-hippocampal levels and a decrease in products associated with neuronal 
cell death (Hashimoto et al., 2002). Additionally, relative to omega-3 adequate rats, those which 
were deficient in neuronal DHA were able to perform simple learning tasks but were impaired 
regarding performance on a more complex, higher-order learning task (Catalan et al., 2002). 
Crucially, the concentrations of DHA and AA have been found to be decreased in the hippocampus 
of older rats, as compared with younger animals, while enriching the diet with omega-3 fatty acids 
has been found to result in full restoration of DHA and partial restoration of AA (McGahon, Martin, 
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Horrobin, & Lynch, 1999). At the neuronal level, age-related decreases in long-term potentiation 
(LTP; an impressive form of synaptic plasticity which is thought to be related to learning and/or 
memory) and glutamate release were also found to be reversed in this study. 
From the evidence reviewed above it appears that omega-3 fatty acids do exhibit great 
potential for providing positive cognitive outcomes in older age, and authorities in the UK have 
recommended levels of intake equivalent to 1-2 portions of oily fish per week (Sanders, 2000). 
However, some important caveats remain. For example, while a wide range of health benefits of 
DHA exist, sufficient attention is not always paid to the recommended dosage of the now widely 
available fish oil supplements. In fact, excessive intake of DHA is capable of disturbing neuronal 
function (Horrocks & Yeo, 1999). Additionally, there has also been concern over the contaminants 
found in some seafood, such as mercury. The benefits associated with seafood consumption do, 
however, seem to outweigh the potential risks (for a review, see Mozaffarian & Rimm, 2006). 
Vitamins C and E 
The brain is particularly vulnerable to the processes of oxidative stress and the free radical action 
which can ultimately result in neuronal cell death (Butterfield et al., 2002). Indeed, free radical-
mediated damage has been implicated in a number of age-related disorders such as AD, and 
Parkinson’s and Huntington’s diseases. Antioxidant substances such as vitamins C and E have the 
ability to inhibit oxidative damage and have therefore been investigated for their potential to slow 
or reverse age-related cognitive decline. 
In a key prospective study, plasma levels of ascorbic acid (vitamin C) in older adults aged 65 
years and over were correlated with measurements taken 22 years earlier (Perrig, Perrig, & Stahelin, 
1997). Plasma antioxidant levels were found to be stable between the two measurement periods, but 
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higher levels at both time points were associated with better performance in a number of memory 
skills (episodic and semantic memory). The relationship between vitamin E intake (assessed by a 
food frequency questionnaire) and the rate of cognitive decline in adults aged 65 years and over has 
also been considered. In that study, during a three year period, a 36% reduction in cognitive decline 
was observed between those individuals categorised as ‘high’ (median = 387.4 IU/day) compared to 
‘low’ (median = 6.8 IU/day) vitamin E consumers (Morris, Evans, Bienias, Tangney, & Wilson, 
2002). The assessed cognitive domains included immediate and delayed recall, and perceptual 
speed, and global performance as measured by the Mini-Mental State Examination (MMSE). 
An important observation in previous research, however, is the synergistic effect of combining 
vitamins C and E, with evidence suggesting an association between supplementation of combined 
vitamins C and E and reduced occurrence of AD (Zandi et al., 2004). Synergism was evident in this 
study due to a protective effect of combined vitamin E (at least 400 IU) and multivitamins 
(containing at least 500 mg of vitamin C), but the absence of protection by vitamin C, vitamin E, or 
multivitamins taken alone. A further longitudinal study reported a reduction in cognitive decline, as 
measured by the modified MMSE, with combined use of vitamins C and E and/or multivitamins 
(Maxwell, Hicks, Hogan, Basran, & Ebly, 2005; dosage and duration data not available). While this 
study was unable to find a protective effect of antioxidant vitamins for the incidence of AD, a 
protective effect for vascular cognitive impairment was identified. 
A recent study has shown that higher cognitive function and a slower rate of cognitive decline 
were associated with total vitamin C intake alone, and in combination with vitamin E, in older 
adults (aged 65 years or over) during a seven year period, as assessed by the modified MMSE 
(Wengreen et al., 2007). The authors concluded that the intake of vitamins C and E may indeed 
delay cognitive decline associated with the aging process. Nonetheless, the results are by no means 
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unequivocal; for example, another study found no such association between vitamins C (mean = 
302 mg/day) and E (mean = 187 IU/day) supplementation and a reduced risk of developing AD 
over a mean follow-up period of 4 years (Luchsinger, Tang, Shea, & Mayeux, 2003). However, 
methodological difficulties should be highlighted since, most notably, relatively low sample size 
and imprecision in the assessment of dietary vitamin intake was problematic in the latter study 
(Luchsinger et al., 2003). 
Overall, the evidence seems to be more reliable for combined antioxidant vitamin intake 
providing protection against age-related cognitive decline. One review, however, which assessed 
the general health (including cognitive) benefits of micronutrient supplementation concluded that 
there is no support for the use of antioxidant vitamin or mineral supplements in well-nourished 
older adults. Additionally, the research has warned of the adverse effects of micronutrient 
supplementation administered at high levels for extended periods of time (Dangour et al., 2004). 
B Vitamins 
Folate (B9) and cobalamin (B12) are two of the B vitamins which are currently being investigated 
for their potential to combat age-related decline, and there is a particular focus on their ability to 
prevent the onset of dementia through their interaction with the neurotoxic substance homocysteine 
(e.g., see Clarke, 2008; Schulz, 2007). Folate is easily absorbed from the diet, but deficiency is 
common at all ages due to “poor diet, malabsorption or alcoholism, or from the use of certain 
drugs” (Clarke, 2008, p.75). In contrast, cobalamin deficiency is associated with malabsorption due 
to digestive disorders such as pernicious anaemia, occurring mainly in older adults, and can result in 
irreversible neurological disorders such as peripheral neuropathy (Clarke, 2008; Rébeillé et al., 
2007). Liver is a particularly rich source of both these micronutrients; however, for folate, the main 
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sources in adults are green leafy vegetables while, for cobalamin, the sources are meat, eggs, and 
dairy products (Rébeillé et al., 2007). 
Folate and cobalamin deficiencies both have the accumulation of homocysteine in common 
[however, cobalamin deficiency also results in increased levels of methylmalonic acid, allowing 
differentiation between the two deficiencies (Rébeillé et al., 2007)]. Furthermore, clinical trials 
have identified homocysteine as a risk factor for vascular disease, and cognitive dysfunction or 
dementia, with elevated levels being detectable years before the dementia presents. For example, 
Dimopoulos et al. (2006) showed that a sample of individuals with dementia had lower levels of 
folate and cobalamin, and higher levels of homocysteine, in comparison with a group of healthy 
controls. A prospective study over a 4.5 year period also found that homocysteine is a risk factor for 
dementia or cognitive impairment without dementia, and that plasma cobalamin can reduce this risk 
(Haan et al., 2007). Notably, however, Haan et al. found no association between red blood cell 
folate and dementia or cognitive impairment, although they stated that this may have been 
influenced by a lack of low folate values. Li et al. (2009) found no independent association between 
plasma total homocysteine and MMSE performance in AD patients but, similarly, for the vast 
majority of participants, homocysteine concentration fell within the normal range. On the other 
hand, Kado et al. (2005) did find folate, but not cobalamin, to be independently predictive of 
cognitive decline over a 7 year period in high functioning adults aged 70 to 79 years. In adults aged 
65 years and above, over a 4 year period, elevated homocysteine levels were also found to be 
associated with an increased risk of both dementia and AD, and low levels of folate, but not 
cobalamin, to be an independent predictor of both dementia and AD (Ravaglia et al., 2007). In 
another prospective study, Morris et al. (2006) found no association between folate intake or 
cobalamin intake and risk of developing AD over a 4 year period. While this study took into 
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account possible confounding by niacin and vitamin E intake levels, it did rely upon participant 
estimations of intake via a food frequency questionnaire. Finally, a recent study by Tassino, 
Campos, and Guerra (2009) showed that homocysteinemia predicted a relatively low proportion 
(4%) of the variance in cognitive function in a group of low-income older Brazilian adults, however 
it is possible that the predictive power would have been larger if more sensitive outcome measures 
had been used. 
It is important to note that some authors argue that elevated homocysteine is not a causative 
factor for dementia, but rather that it provides a marker of vascular disease (e.g., see Seshadri, 
2006). Indeed, Mooijaart et al. (2005) showed that, although elevated homocysteine levels and 
reduced folate levels were associated with cognitive impairment in older adults aged 85 years, these 
factors did not predict an increased rate of cognitive decline over the following 4 years. Notably, 
cobalamin was neither associated with cognitive impairment at baseline, nor predictive of rate of 
cognitive decline thereafter. These authors suggested that low folate levels and high homocysteine 
levels could be a consequence of cognitive impairment due to poor eating habits rather than a 
contributory cause. Tangney, Tang, Evans, and Morris (2009), who investigated levels of 
methylmalonic acid, a more specific marker of cobalamin deficiency than homocysteine, found that 
higher serum concentrations of methylmalonic acid and lower cobalamin were both associated with 
faster rates of cognitive decline over a 6 year period. Furthermore, Feng, Li, Yap, Kua, and Ng 
(2009) recently showed that the positive association between cobalamin and cognitive function is 
moderated by APOE ε4 status, with a stronger association present in ε4 carriers. 
Two recent randomized, double-blind, placebo-controlled trials have been carried out to 
investigate the possible cognitive benefits of folate and cobalamin supplementation. Durga et al. 
(2007) administered adults, aged 50-70 years, either 800 μg/day of oral folic acid or a placebo for a 
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period of 3 years. The participants were expected to benefit from the homocysteine-lowering effects 
of folic acid, with plasma total homocysteine levels greater than 13 μmol/L (additionally, those with 
levels >26 μmol/L were excluded, where concentrations were possibly due to factors other than 
suboptimal folate level). Global cognitive performance and, more specifically, the domains of 
memory, information processing speed, and sensorimotor speed, were improved by folic acid 
supplementation, while the complex speed and word fluency domains showed no benefit. Eussen et 
al. (2006) investigated the effects of 24 wk supplementation with high doses of cobalamin (1000 
μg/day), or with cobalamin (1000 μg/day) plus folic acid (400 μg/d), in older adults with a mild 
cobalamin deficiency, aged 70 years or above. Cobalamin supplementation corrected the mild 
deficiency and reduced homocysteine levels by 16%, while cobalamin plus folic acid 
supplementation increased red blood cell folate concentrations, and decreased homocysteine levels 
by 36%. In this study, neither cobalamin supplementation alone, nor cobalamin with folate 
supplementation, were found to improve cognitive performance as measured by an extensive 
battery of tests, which assessed a number of domains including attention, memory, and 
sensorimotor speed. While this brings into question the efficacy of cobalamin supplementation, the 
relatively short-term duration of the supplementation may have limited the effects. A similar trial 
carried out over the longer term would therefore be welcomed. 
While there is clear evidence for an association between folate and cobalamin levels and 
cognitive performance in older age, trials have thus far provided limited evidence of the cognitive 
benefits of folate, and disappointing results for cobalamin. The evidence appears more convincing 
for folate supplementation, such that there is clear ground for further evaluation. Indeed, further 
investigation is particularly relevant, given that excessive intakes of folate in older adults can result 
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in delayed diagnosis of cobalamin deficiency and therefore more rapid progression of the related 
neuropathy or cognitive impairment (Clarke, 2008). 
Fruit and Vegetable Polyphenols 
Flavonoids, present in colourful flowers and fruits, comprise the largest group of polyphenols, 
which are substances found in fruits, vegetables, and some plants. Polyphenols can protect against 
cell death and some possess anti-inflammatory properties. Because of this, they could be suitably 
used in conditions such as AD, which is characterized by oxidative stress and inflammation, and in 
which the level of antioxidant defence becomes depleted (Butterfield et al., 2002). Furthermore, the 
combination of antioxidant and anti-inflammatory polyphenolic compounds found in fruit and 
vegetables, although not involved in the food plant’s primary metabolism, increase its ability to 
survive, and therefore may offer humans beneficial effects during the aging process (for a review, 
see Joseph, Shukitt-Hale, & Casadesus, 2005). Indeed, a large prospective study of the relationship 
between fruit and vegetable consumption (extending over a period of 10-16 years), indicated that 
vegetable intake is related to reduced cognitive decline (Kang, Ascherio, & Grodstein, 2005). This 
was particularly the case for green leafy vegetables (e.g., spinach and romaine lettuce) and 
cruciferous vegetables (e.g., broccoli and cauliflower). In addition, the protective effects of dietary 
polyphenols have also been reported for non-fruit and vegetable sources; for example, it has been 
shown that the intake of flavonoids (known to be present in wine) is negatively related to the 
incidence of AD (Commenges et al., 2000). 
Research with rodents has greatly contributed to the growing body of evidence indicating the 
positive outcomes of fruit and vegetable polyphenols. For example, rats supplemented with either 
strawberry extracts (9.5 gm/kg), spinach extracts (6.4 gm/kg), or vitamin E (500 IU/kg) over the 
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long-term (8 months) exhibited retarded onset of age-related neuronal and cognitive deficits (Joseph 
et al., 1998). It may be worth noting that, because the spinach condition resulted in the greatest 
overall benefits, the authors questioned whether the phytochemicals present in fruit and vegetables 
may offer some other mechanism of protection over and above the antioxidant and anti-
inflammatory ones (Joseph et al., 1998; 2005). Further research showed that 8-week 
supplementation with spinach (9.1 gm/kg), strawberry (14.8 gm/kg), or blueberry (18.6 gm/kg) 
improved age-related cognitive deficits, but that only blueberry supplementation improved motor 
function (Joseph et al., 1999). In a further study utilizing a rodent model, it was found that 
supplementation with antioxidant-rich blueberries (20 gm/kg) from 4 to 12 months of age 
normalised spatial memory deficits in AD (Joseph et al., 2003), and it has been argued that the 
pattern of results suggests the involvement of phytochemicals in mechanisms of protection other 
than antioxidant ones, such as alterations in neuronal signalling (Joseph et al., 2005; see also 
Shukkitt-Hale, Lau, & Joseph, 2009). Polyphenolic compounds present in blueberries are able to 
cross the blood-brain barrier and, following blueberry supplementation in rats, have been found in a 
number of brain areas including the hippocampus. Additionally, the presence of polyphenolic 
compounds has been positively correlated with cognitive performance (Andres-Lacueva et al., 
2005). Indeed, recent work by Papandreou et al. (2009) showed that short-term supplementation 
with 60 mg/kg of wild blueberry extract over the short-term (7 days) resulted in enhanced learning 
and memory performance which was related not only to higher brain antioxidant properties but also 
to inhibition of acetylcholinesterase activity. Other evidence suggests that the beneficial effect of 
blueberries on spatial memory is mediated, at least in part, by their effect on hippocampal plasticity 
via increased neurogenesis (Casadesus et al., 2004), and these authors stated that it remains to be 
seen whether or not the cognitive enhancement of blueberries would also be observed in humans. It 
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is important that treatments be developed which can mimic the actions of blueberries in rats in order 
to help slow, or even reverse, age-related cognitive and neuronal decline. 
Similar to the beneficial effect of blueberries, Concord grape juice, another substance high in 
antioxidant and anti-inflammatory properties, has been shown to exert a positive, dose-response 
effect upon cognitive and motor function in aged rats (Shukitt-Hale, Carey, Simon, Mark, & Joseph, 
2006). In this study cognitive enhancement was found with 10% grape juice, while enhancement in 
motor performance was found with a 50% concentration. The authors interpreted these and previous 
(Joseph et al., 1999) results as showing that enhancements of motor performance are more difficult 
to achieve and require larger amounts of polyphenols. However, it remains questionable why the 
50% grape juice did not exert an effect on cognitive deficits and the authors have found this 
difficult to explain. They have speculated that the effect of grape juice may exhibit an optimal 
dosage on some outcome measures. The variety of effects exerted by the polyphenols present in 
fruits and vegetables may reflect a synergistic effect beyond simply antioxidant or anti-
inflammatory ones and, in the example of the Concord grape, the whole may be greater than the 
sum of its parts (Shukitt-Hale et al., 2006). This argument may also explain why some studies 
discussed above have failed to observe beneficial effects of just one or two antioxidant vitamins. 
Ginkgo Biloba 
The health benefits relating to the ingestion of numerous herbal products, and their active 
phytochemicals, have been a matter of debate for many years. Many of these studies have utilized 
rodent models and a range of methodologies in human populations (e.g., epidemiological, cross-
sectional, and prospective). Particularly relevant to the present review are the purported protective 
effects against natural aging (both relating to a decline in cognitive ability and health status) or 
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against those pathologies where aging is a major risk factor (e.g., dementia), and only those studies 
which have utilized placebo-controlled, double-blind protocols can be seen as clinically relevant. 
One such herbal supplement, Ginkgo biloba, has been studied extensively, with regard to its effects 
on both behavior and physiological parameters (Maclennan, Darlington, & Smith, 2002). Ginkgo 
biloba is of particular interest as the active chemicals (flavonoids, biflavonoids and terpenes; Gold, 
Cahill, & Wenk, 2002) have been shown to exert a broad range of biochemical and pharmacological 
actions. These include antioxidant and free radical scavenging effects, as well as hemodynamic and 
neurotransmitter effects, all of which may be relevant to aging and age-related disorders 
(Maclennan et al., 2002). These studies may go some way to validating the current status of the 
herb in Germany and France. In these countries it is currently prescribed for the treatment of 
cerebral insufficiency, and is recommended both for age-related cognitive decline and for slowing 
the progress of neurodegenerative disorders such as AD. However, in the UK, Canada, and the 
USA, it is marketed as an over-the-counter food supplement. 
Despite Ginkgo’s current status and the plethora of in vitro/animal data, research relating to 
the clinical efficacy of the substance in human populations is not clear. For example, individual 
studies have reported improved cognitive performance following 26 weeks (Le Bars, Kieser, & Itil, 
2000) and 52 weeks (Le Bars et al., 1997) of Ginkgo supplementation (120 mg/day) in an AD 
population. Similarly, a recent review suggested that there is a small, but significant, effect of 3 to 6 
months of treatment with 120 to 140 mg/day on objective measures of cognitive function in AD 
(Oken, Storzbach, & Kaye, 1998). However, others studies have shown no positive impact upon 
natural brain aging in healthy older adults (60 – 82 years) following 120 mg/day for 6 weeks. In 
addition, a recent review showed that there was no systematic and clinically meaningful effect of 
Ginkgo on any cognitive measure employed, involving patients with a mild or moderate stage of 
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dementia (van Dongen, van Rossum, Kessels, Sielhorst, & Knipschild, 2000). Indeed, in a recent 
meta-analysis, Birks and Grimley Evans (2009, p.2) concluded “evidence that Ginkgo has 
predictable and clinically significant benefit for people with dementia or cognitive impairment is 
inconsitent and unreliable”. Although attempts to bring clarity should be applauded, such a negative 
conclusion may be somewhat premature and may be attributed to the disparity in methodologies, 
extracts investigated, and populations studied, let alone the fact that there are few clinical studies 
available for review. As stated by the authors, out of the 36 available studies, only 30 possessed 
adequate methodologies and, of these, 15 contribute very few data. Additionally, although the 
effects of Ginkgo biloba were reported in terms of global outcomes (e.g., global, cognitive function, 
ADLs, mood and emotional function) around a 12 week treatment period, it is apparent that there is 
very little similarity between the majority of studies in terms of design, duration, assessment 
method, study population, and the extract investigated to allow specific conclusions to be drawn. 
Thus, while there is a wealth of evidence relating to the physiological effects of Ginkgo biloba 
which may underlie human health and behavior, the evidence relating to its clinical efficacy 
remains unclear and warrants further investigation. 
Summary 
Given the fact that human beings are living longer and that aging is a major risk factor for disease 
progression (particularly in AD), it is not unexpected that a greater proportion of the population will 
show varying degrees of cognitive decline. As this ‘new’ population grows we will be faced with 
untold economic costs, in terms of care facilities, family responsibility, and drug development. It 
therefore seems timely to investigate further the potential interventions employing the use of 
nutritional substances. This review has focused on compounds which have received a great deal of 
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attention in the media, particularly those which may slow the aging process. Omega-3 fatty acids 
have consistently been shown to offer protection against cognitive decline, such that consumption 
of 1-2 portions of oily fish per week is now recommended. Fruit and vegetable polyphenols also 
offer great promise; however, much of the evidence is based upon research using rodents rather 
than human subjects. Antioxidant vitamins C and E, the B vitamins folate and cobalamin, and the 
herbal extract Ginkgo biloba, have produced more mixed findings: combined vitamin C and E 
intake may offer more protective power, while limited benefits of Ginkgo biloba and the B vitamins 
have been observed. Overall, the potential clinical efficacy of such substances is clear, but further, 
well-controlled clinical trials are required before reliable conclusions can be drawn. 
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